CurrentRheuma coverage · page 6 of 15
Annals of the Rheumatic Diseases
Latest from Annals of the Rheumatic Diseases
Ann Rheum Dis
Ann Rheum Dis
A germline IκBα mutation outside the signal reception domain blocks nuclear translocation of NFκB1 and associates with autoinflammation-like features
Mechanistic studyAutoinflammatory & rare
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
Mechanistic studyLupus & APS
Ann Rheum Dis
Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis
Randomized controlled trialVasculitis & PMR
Ann Rheum Dis
Ann Rheum Dis
SLE classification criteria item relationships: implications on SLE as a disease entity
Cross-sectional studyLupus & APS
Ann Rheum Dis
Ann Rheum Dis
Cannabidiol versus placebo in patients with fibromyalgia: a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial
Randomized controlled trialFibromyalgia & pain
Ann Rheum Dis
Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome
Mechanistic studyLupus & APS
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis
Randomized controlled trialVasculitis & PMR
Ann Rheum Dis
Global recruitment patterns and placebo responses in clinical trials of rheumatoid arthritis
Randomized controlled trialRA
Ann Rheum Dis
HLA loci heterozygosity modulates genetic risk in idiopathic inflammatory myopathies
Case-control studyMyositis
Ann Rheum Dis
A glossary of signs and symptoms of giant cell arteritis
Guideline or statementVasculitis & PMR
Ann Rheum Dis
Ann Rheum Dis
BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis
Research articleLupus & APS
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Effects of different B-cell-depleting strategies on the lymphatic tissue
Mechanistic studyAcross diseases
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis
Diagnostic or prognostic studyAutoinflammatory & rare
Ann Rheum Dis
Development of an MHC imputation panel highlights independent contributions of HLA amino acid residues and C4 copy number variations to SLE risk
Diagnostic or prognostic studyLupus & APS
Ann Rheum Dis
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b study
Randomized controlled trialSpondyloarthritis & PsA
Ann Rheum Dis
Ann Rheum Dis
Antimitochondrial antibodies in systemic sclerosis target enteric neurons and are associated with GI dysmotility
Cross-sectional studySystemic sclerosis
Ann Rheum Dis
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies
Cohort studyAutoinflammatory & rare
Ann Rheum Dis
Ann Rheum Dis
Ann Rheum Dis
The Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) definition of clinical remission in gout
Guideline or statementGout & crystals
Ann Rheum Dis
Ann Rheum Dis
Exploring the limit of image resolution for human expert classification of vascular ultrasound images in giant cell arteritis and healthy subjects: the GCA-US-AI project
Diagnostic or prognostic studyVasculitis & PMR
Ann Rheum Dis
Integrative exome sequencing and machine learning identify MICB and interferon pathway genes as contributors to SSc risk
Cohort studySystemic sclerosis